Applied Ventures

Applied Ventures, LLC is the venture capital fund of Applied Materials, Inc., (NASDAQ: AMAT), the global leader in nanomanufacturing technology solutions for the electronics industry with a broad portfolio of innovative equipment, service, and software products. At Applied Materials, they apply nanomanufacturing technology to improve the way people live. Applied Ventures invests in early-stage technology companies that promise to deliver high growth and exceptional returns. Their charter is to profitably invest in companies that provide a window on technologies that advance or complement Applied Materials' core expertise. Their investments help develop technologies and markets that provide natural extensions to Applied Materials' core business and stimulate the growth of applications for semiconductors, displays, solar PV, and related products and services.

Anand Kamannavar

Founder and Global Head

Jackie Kossmann

Investor

Frank Lee

Senior Investment Director

Past deals in Nanotechnology

Scintil Photonics

Venture Round in 2022
SCINTIL Photonics is a fabless company that develops silicon photonic integrated circuits. SCINTIL solutions combine the best of Silicon (Si) and Indium Phosphide (InP) materials using wafer-scale bonding of InP on Si and rely on commercial silicon foundry processes to build fully integrated photonic circuits (comprising multi-wavelength lasers, waveguides, wavelength filters, and photodetectors).

Exo

Series B in 2020
Exo is a medical device startup focused on developing a handheld ultrasound platform for imaging and therapeutic applications. The company aims to provide affordable and user-friendly medical imaging solutions for healthcare professionals globally. By integrating advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost efficiencies of semiconductor manufacturing, Exo significantly lowers the costs associated with medical imaging. This technology allows healthcare providers to make vital, real-time decisions that enhance patient outcomes. Exo's commitment to high-quality, accessible imaging represents a significant advancement in medical technology, making effective diagnostic tools available at an unprecedented price point.

Inpria

Series C in 2020
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Exo

Series A in 2017
Exo is a medical device startup focused on developing a handheld ultrasound platform for imaging and therapeutic applications. The company aims to provide affordable and user-friendly medical imaging solutions for healthcare professionals globally. By integrating advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost efficiencies of semiconductor manufacturing, Exo significantly lowers the costs associated with medical imaging. This technology allows healthcare providers to make vital, real-time decisions that enhance patient outcomes. Exo's commitment to high-quality, accessible imaging represents a significant advancement in medical technology, making effective diagnostic tools available at an unprecedented price point.

Inpria

Series B in 2017
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Exo

Venture Round in 2017
Exo is a medical device startup focused on developing a handheld ultrasound platform for imaging and therapeutic applications. The company aims to provide affordable and user-friendly medical imaging solutions for healthcare professionals globally. By integrating advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost efficiencies of semiconductor manufacturing, Exo significantly lowers the costs associated with medical imaging. This technology allows healthcare providers to make vital, real-time decisions that enhance patient outcomes. Exo's commitment to high-quality, accessible imaging represents a significant advancement in medical technology, making effective diagnostic tools available at an unprecedented price point.

Inpria

Venture Round in 2014
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Inpria

Venture Round in 2014
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

ActaCell

Series A in 2008
ActaCell, Inc. is a technology start-up focused on commercializing advanced lithium-ion battery technology developed at The University of Texas at Austin. The company's innovations aim to provide significantly longer cycle life at a lower cost while prioritizing safety. ActaCell's energy storage solutions utilize a nanocomposite alloy anode material as a replacement for traditional graphite, enhancing efficiency and longevity in high-energy applications. The company secured $5.8 million in Series A financing in July 2008, led by DFJ Mercury and supported by investors such as Google.org's RechargeIT program and Applied Ventures, LLC. These funds are intended to recruit essential technical talent and further advance ActaCell's battery technology for commercial use.

Grandis

Venture Round in 2005
Grandis is a pioneer in the development and licensing of innovative non-volatile memory solutions based on advanced research in spintronics. The company specializes in spin transfer torque random access memory products, which are designed to store, manipulate, and transmit information for the semiconductor industry. Grandis licenses these products to technology companies engaged in the design, development, and manufacturing of consumer electronics, personal computers, as well as equipment used in automotive, medical, military, and space applications. The company's mission is to facilitate the creation of revolutionary products through the application of the electron's spin.

Grandis

Series A in 2003
Grandis is a pioneer in the development and licensing of innovative non-volatile memory solutions based on advanced research in spintronics. The company specializes in spin transfer torque random access memory products, which are designed to store, manipulate, and transmit information for the semiconductor industry. Grandis licenses these products to technology companies engaged in the design, development, and manufacturing of consumer electronics, personal computers, as well as equipment used in automotive, medical, military, and space applications. The company's mission is to facilitate the creation of revolutionary products through the application of the electron's spin.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.